Glucocorticoids are the most potent treatment of inflammatory airway disease such as asthma (1) . However the cellular mechanisms involved in the response to glucocorticoids are not fully elucidated, and in particular, early cellular effects of corticotherapy are relatively unknown. Glucocorticoids are recognized to produce their pharmacological effects through a classical genomic pathway involving binding to a specific cytosolic receptor, translocation into the nucleus, and subsequent activation (transactivation) or repression (transrepression) of a target gene transcription. The anti-inflammatory properties of glucocorticoids are explained by the transrepression of genes coding for inflammatory molecules. In intestinal and renal epithelial cells, glucocorticoids stimulate the expression of mRNA coding for the Na ϩ /H ϩ exchanger, one of the most important intracellular pH regulators in epithelial cells (2, 3) . The genomic effects of steroids are characterized by a latency of onset lasting several hours.
In contrast, over the past decade, many steroid hormones have been reported to induce rapid responses (seconds to minutes) in various signal transduction pathways and ion transport. These fast responses are incompatible with the involvement of the classical genomic pathway for steroid hormone action. Rapid effects of glucocorticoids have been described in several tissues such as endometrial cells (4) , vascular smooth muscle (5, 6) , and renal cortical collecting duct (7) . However, the cellular and molecular mechanisms involved are only partially described, and their physiological roles have not been elucidated (8, 9) . In airway epithelial cells, dexamethasone produced a rapid decrease of intracellular [Ca 2ϩ ] and inhibited Ca 2ϩ -dependent Cl Ϫ secretion through a nongenomic mechanism (10) . In vascular smooth muscle cells, glucocorticoids have been shown to stimulate rapidly the Na ϩ /H ϩ exchanger activity through a mechanism independent of gene transcription and protein synthesis (6) . In epithelia, the mineralocorticoid hormone, aldosterone, also stimulates the Na ϩ /H ϩ exchanger activity through a nongenomic mechanism (11) (12) (13) . A nongenomic effect of glucocorticoids on pH i regulation in airway epithelium has not been described previously.
MATERIALS AND METHODS
Cell Culture-Epithelial cells were grown in Corning culture flasks coated with a collagen/fibronectin solution at 37°C in a humidified 5% CO 2 atmosphere. The human bronchial epithelial cell line 16HBE14o Ϫ was derived from the surface epithelium of mainstream, second generation bronchi. The 16HBE14o Ϫ cells form polarized monolayers with intact tight junctions and retain chloride transport properties and other differentiated features characteristic of freshly isolated surface airway epithelial cells (14) . The 16HBE14o Ϫ cells were grown in Eagle's minimal essential medium supplemented with 10% fetal calf serum, 1% penicillin G, 1% streptomycin, and 1% L-glutamine. After reaching confluence, the cells were washed twice with a phosphate-buffered saline solution and isolated at 37°C, using a trypsin solution (1% polyvinylpyrrolidone, 0.2% EGTA, and 0.25% trypsin containing 0.02% EDTA). pH i Measurement-For pH i measurements, human bronchial epithelial cells were grown on collagen/fibronectin-coated glass bottom dishes (12 mm diameter) and loaded with the pH-sensitive dye 2Ј,7Ј-bis(carboxyethyl)-5,6-carboxyfluorescein by incubating the cells in 5 M of 2Ј,7Ј-bis(carboxyethyl)-5,6-carboxyfluorescein-AM (Molecular Probes) for 60 min at 37°C. The cells were bathed in a modified Krebs solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 2 mM MgSO 4 , 10 mM HEPES, pH 7.4). All experiments were performed in the dark and at room temperature to minimize dye leakage. The glass bottom dishes were mounted on an inverted epi-fluorescence microscope (Diaphot 200, Nikon). The ultraviolet light from a xenon 100-watt lamp (Nikon) was filtered through alternating 440 and 505 nm interference filters using the OptoScan-CAIRN monochromator (CAIRN-DIPSI, Chatillon, France), which allowed an electronic adjustment of the duration of the exposure to each wavelength. The resultant fluorescence was filtered at 510 nm and collected using an intensified CCD camera system (CoolSNAP-fx, Roper Scientific-Princeton Instrument, Evry, France). Images were digitized and analyzed using Metafluor (Universal Imaging-Princeton Instrument, Evry, France). The ratio of fluorescent signals emitted at each excitation wavelength was calibrated using nigericin (15) . The frequency of acquisition was 1 ratiometric image every 500 ms. The basal pH i (steady-state pH i ) was calculated as the average of 1 min of acquisition under control conditions. The hormonal effect on pH i regulation was investigated under intracellular acid loading conditions using the ammonium chloride (NH 4 Cl ϭ 20 mM) pre-pulse technique (16 
The acid load was carried out in the absence of extracellular Na ϩ in order to prevent acid extrusion. As shown in Fig. 1 , the pH i dependence of the intracellular buffering power was evaluated by plotting the ␤ i values as a function of the pH i measured at midpoint of the acid load ( Fig. 1) . The intrinsic buffering power of the two cell populations used to serve as control and to investigate the dexamethasone response was not significantly different (mean ␤ i control is 15.01 Ϯ 0.3, mean ␤ i for dexamethasone experiment is 14.65 Ϯ 0.182). Furthermore, the pH i dependence of the buffering power was not significantly different for the two control and dexamethasone-treated cell populations (Fig. 1) . The H ϩ flux after the acid load was calculated as the product of the buffering power, ␤ i , and the initial rate of pH i regulation (⌬pH i /dt) was measured over 60 s at any given pH i : J H ϭ ␤ i ϫ ⌬pH i /dt. For each experiment, 10 -15 cells were imaged simultaneously.
Preparation of Cell Lysates-The 16HBE14o
Ϫ cells (5 ϫ 10 5 /ml) were incubated under serum-free conditions overnight and then exposed to experimental drug treatment, if any, and stored on ice. The media were replaced with 1 ml of ice-cold phosphate-buffered saline for 1 min (pH 7.2). The phosphate-buffered saline wash was replaced with 150 l of homogenization buffer (20 mM Tris, 1 mM EGTA, pH 7.4, 10 mg/ml bovine serum albumin, 100 mM phenylmethylsulfonyl fluoride, 1 mM 1,4-dithiothreitol, and 1 mM protease inhibitor mixture). Cells were lysed by Soniprep microprobe sonication for 15 s (Sanyo, Osaka Japan).
Detection of cAMP-dependent Protein Kinase Activity-cAMP-dependent protein kinase (PKA) 2 activity was assayed using the Promega PepTag assay for nonradioactive detection of cAMP-dependent protein kinase (Promega, Madison, WI). Lysates were prepared as above and assayed immediately. All PepTag assay reaction components were combined on ice, and PKA activity was assayed at 30°C for 20 min, in a final volume of 30 l of the following mixture: 5 l of 5ϫ reaction buffer, 5 l of formyl-Leu-Arg-Arg-Ala-Ser-Leu-Gly (f-Kemptide) PepTag buffer, 5 l of water, and 15 l of sample homogenate (10 g of protein) or 10 ng of commercial catalytic C subunit. The reaction was stopped after 20 min by incubating the tubes at 95°C for 10 min. Before loading samples on previously prepared electrophoresis gel (0.8% agarose in 50 mM Tris buffer, pH 8.0), 2 l of 80% glycerol was added to the sample. Electrophoresis was run at 110 V for 30 min and was imaged under UV light by a GeneSnap Program.
Detection of MAP Kinase Activity by Western Blotting-Cells were pretreated with inhibitors H89 (10 M) and PD98059 (25 M) for 40 min and then exposed to dexamethasone (1 nM) or methanol for 20 min, and lysates were prepared as above. Proteins were separated on 10% SDSpolyacrylamide gels and transferred to polyvinylidene difluoride membranes. Membranes were incubated with rabbit phospho-p44/42 MAP kinase (Thr-202/Tyr-204) primary antibody at a dilution of 1:2,000 (Cell Signaling, 9101S), washed, and incubated with an anti-rabbit IgG horseradish peroxidase-conjugated secondary (Sigma A9169) at a dilution of 1:4,000. For loading controls, membranes were washed and incubated with mouse IgG anti-␤-actin primary antibody (1:2000 Sigma A5316), washed, and incubated with an anti-mouse IgG horseradish peroxidaseconjugated secondary (Sigma A9169) at a dilution of 1:20,000. Detection was carried out using the ECL Plus Western blotting system (Amersham Biosciences). Quantitative gel banding densitometry was performed using Gene Tools (SynGene, Cambridge, UK). Data Analysis-Data are shown as the mean Ϯ S.E. of n cells for pH i measurement or of n experiments for PKA and MAP kinase detection. Measures of statistical significance were obtained using either Student's t test for paired data or one-way analysis of variance for multiple testing. A p value of less than 0.05 was deemed to be significant. Statistical operations were performed using Excel software (Microsoft) or GraphPad InStat version 3.05 for Windows 95 (GraphPad Software, San Diego).
RESULTS

pH i Changes during an Acid Load-The regulation of intracellular pH in human bronchial epithelial cells (16HBE14o
Ϫ cell line) was studied using the acid-loading NH 4 Cl pre-pulse method (16) . In control Krebs solution, the steady-state pH i was 7.47 Ϯ 0.01 (n ϭ 120). As shown in Fig. 2 n ϭ 95, p Ͻ 0.001). These results indicate that the pH i recovery after an acid load is mainly dependent on Na recovery from an acid load under dexamethasone stimulation was tested by removal of external Na ϩ and by addition of the Na ϩ /H ϩ exchanger inhibitor EIPA. As shown on Fig. 3 , A and C, when cells were exposed to EIPA after the acid load, the dexamethasone stimulation of the pH i recovery was inhibited (p Ͻ 0.001). When Na ϩ was absent from the bathing solution (NMDG substitution) after the acid load, the dexamethasone effect on pH i recovery was also inhibited. In bronchial epithelial cells bathed with NMDG solution, the ⌬pH i obtained after the acid load in the presence of dexamethasone (1 nM) was 0.021 Ϯ 0.003 pH units/min (n ϭ 54). This contrasts with the high rate of pH i recovery stimulated by dexamethasone (1 nM) in the presence of extracellular Na ϩ (⌬pH i ϭ 0.114 Ϯ 0.004 pH i units/min, n ϭ 57, p Ͻ 0.001). These experiments indicate the complete Na ϩ dependence and the major role of the Na ϩ /H ϩ exchanger in the dexamethasone-induced stimulation of pH i recovery following an acid load. In order to further investigate the effect of dexamethasone on the Na ϩ /H ϩ exchanger activity, we compared the J H at different starting pH i values of the pH regulation phase with or without dexamethasone.
The J H has been calculated for each single cell (using the ⌬pH/dt recorded during 1 min) and expressed as a function of the lowest pH i measured in each cell at that time (Fig. 3D) . We determined the EIPAsensitive component of the pH i recovery from an acid load at each of the various pH i starting values during the recovery phase. The contribution of the Na ϩ /H ϩ exchanger to the pH i recovery (⌬pH/dt because of the Na ϩ /H ϩ exchanger) has been calculated by subtracting the EIPA-insensitive ⌬pH/dt at a given pH i from the total ⌬pH/dt measured at the corresponding control pH i (without EIPA). The pH i dependence of the exchanger was computed as the product of the ⌬pH i /dt and the buffering power and plotted as a function of the initial pH i (Fig. 3D) .
Fluticasone and Aldosterone Effects on the pH i Recovery-In order to test steroid specificity, the effects on pH i regulation of the mineralocorticoid, aldosterone and the glucocorticoid, fluticasone were also investigated. As shown in Fig. 4A , fluticasone at 1 nM produced a faster pH i recovery rate than dexamethasone used at the same concentration. Fluticasone stimulated a pH i recovery rate of 0.173 Ϯ 0.005 pH i units/min (n ϭ 52). On the other hand, aldosterone (1 nM) did not significantly increase the pH i recovery rate after an acid load. The pH i recovery rate in the presence of aldosterone treatment was 0.051 Ϯ 0.002 pH i units/ min (n ϭ 51), which was not significantly different from the pH i recovery obtained under control conditions in the absence of the mineralocorticoid (p Ͼ 0.1).
RU486 and Spironolactone Effects on the pH i
Response to Dexamethasone-The enhanced pH i response to fluticasone and the lack of response to aldosterone suggest that the rapid dexamethasone regulation of pH i is a glucocorticoid-specific effect that may be mediated through the nuclear glucocorticoid receptor. In order to investigate the receptor type involved in the response to dexamethasone, we used RU486 and spironolactone as antagonists of the nuclear glucocorticoid receptor and mineralocorticoid receptor, respectively. In control experiments, we verified these receptor antagonists did not affect pH i regulation. Neither RU486 (⌬pH i ϭ 0.047 Ϯ 0.003 pH i units/min, n ϭ 54) nor spironolactone (⌬pH i ϭ 0.054 Ϯ 0.002 pH i units/min, n ϭ 58) treatment significantly affected the pH i recovery rate under control conditions in the absence of steroid hormone. In addition, as shown in pH i Response to Dexamethasone in the Presence of CycloheximideThe rapidity (seconds) of the dexamethasone effect on pH i regulation suggests that this fast response does not involve a classical genomic mechanism. In order to verify this hypothesis, we tested the dexamethasone response in the presence of cycloheximide, an inhibitor of mRNA translation. As shown in Fig. 4 , cycloheximide (1 M) did not significantly affect the pH i response to dexamethasone, indicating a nongenomic mechanism of action (⌬pH i ϭ 0.103 Ϯ 0.00 pH i units/min with dexamethasone 10 Ϫ9 M ϩ cycloheximide, n ϭ 57). The inhibitor data, taken together, indicate the rapid effect of dexamethasone on pH i regulation in human airway epithelial cells is a nongenomic response that does not involve the nuclear glucocorticoid or the mineralocorticoid receptors.
Role of cAMP-dependent Protein Kinase in the pH i Response to
Dexamethasone-A possible role for the PKA signaling pathway in the rapid steroid response was tested using (R p )-cAMP, a competitive inhibitor of PKA activity and the PKA inhibitor 14-22 amide myristoylated (PKAI). Pretreatment with (R p )-cAMP did not affect the control pH i regulation following an acid load; however, PKAI partially inhibited pH i recovery under control conditions. In contrast, the dexamethasoneinduced pH i regulation was affected by the PKA antagonists. The pH i recovery rate in the presence of dexamethasone was 0.056 Ϯ 0.002 pH i units/min (n ϭ 57) in the presence of (R p )-cAMP and 0.046 Ϯ 0.001 pH i units/min (n ϭ 56) with PKAI. These recovery rates were significantly reduced compared with the pH i recovery rate of 0.101 Ϯ 0.004 (n ϭ 59) obtained with dexamethasone alone (Fig. 5A) .
Role of MAP Kinase (ERK1/2) Activity in the pH i Response to Dexamethasone-The role of the ERK1/2 signaling pathway was investigated using the MAPK inhibitor PD98059 (25 M). As shown in Fig.  5B , PD98059 did not affect the basal pH i recovery rate after an acid load under control conditions (⌬pH i ϭ 0.040 Ϯ 0.004 pH i units/min, n ϭ 23) but did inhibit the pH i recovery stimulated by dexamethasone (10 nM) (⌬pH i ϭ 0.059 Ϯ 0.003 pH i units/min, n ϭ 38). The simultaneous application of PD98059 and PKAI did not produce an additive inhibitory effect on the dexamethasone response (Fig. 5C) . i Response to Dexamethasone-The role of G protein-coupled receptors in the rapid response to dexamethasone was investigated using pertussis toxin (2 g/ml). As shown in Fig. 6 , pertussis toxin did not affect the basal pH i recovery rate after an acid load under control conditions (⌬pH i ϭ 0.056 Ϯ 0.003 pH i units/min, n ϭ 21) but significantly inhibited the pH i recovery stimulated by dexamethasone (10 Ϫ9 M) (⌬pH i ϭ 0.074 Ϯ 0.003 pH i units/min, n ϭ 52, p Ͻ 0.001).
Role of Pertussis Toxin-sensitive G Protein-coupled Receptors in the pH
Dexamethasone Effect on cAMP-dependent Protein Kinase ActivityAs shown in Fig. 7 , PKA activity was up-regulated in less than 5 min by 40% over control (p Ͻ 0.01) following 1 nM dexamethasone treatment. The G i protein inhibitor, pertussis toxin (10 g/ml), inhibited the activation of PKA by dexamethasone. The cells pretreated with pertussis toxin before dexamethasone did not show a significantly increased phosphorylation compared with untreated control cells (p Ͼ 0.1). In contrast, the ERK1/2 inhibitor, PD98059 (50 M), had no significant effect on PKA activation by the steroid (p Ͼ 0.1). In these experiments, the adenylate cyclase activator, forskolin, and the PKA antagonist, (R p )-cAMP, were used as positive and negative controls for PKA stimulation, respectively. The PKA phosphorylation was not significantly increased with methanol (dexamethasone solvent) compared with the negative control (p Ͼ 0.1).
Dexamethasone Effect on the MAP Kinase Activity-As shown in Fig.  8 , dexamethasone (1 nM) stimulated MAP kinases (Erk1 and Erk2) phosphorylation in 16HBE14o Ϫ cells (p Ͻ 0.05) in less than 5 min (lane 3). The rapid activation of MAPK by dexamethasone was significantly inhibited (p Ͻ 0.05) by the PKA inhibitor H89 (Fig. 8, lane 4) and the MAP kinase inhibitor PD98059. The basal MAP kinase activity was completely abolished by the PD98059 (Fig. 8, lane 7) but not by H89 (lane 6). Neither forskolin nor methanol affected MAPK activity (Fig. 8,  lanes 1 and 2) . These results indicated that the basal MAP kinase phosphorylation in 16HBE14o Ϫ did not require PKA activity, whereas dex- amethasone induced a MAP kinase activation depending on upstream PKA activity.
DISCUSSION
In this paper, we provide evidence for the rapid stimulation of Na ϩ /H ϩ exchanger activity by dexamethasone in human bronchial epithelial cells via a nongenomic mechanism. This response does not involve the glucocorticoid nor the mineralocorticoid nuclear receptors but acts via PKA and ERK1/2 MAP kinase signaling pathways. (21, 22) . However, in our study, all the experiments were performed in HEPES-buffered and HCO 3 Ϫ -free medium, which reduces the contribution of Cl Ϫ /HCO 3 Ϫ exchange to pH i regulation. In addition, we showed that EIPA (100 M) produced a rapid and significant decrease of the basal pH i , indicating a contribution from the Na ϩ /H ϩ exchanger activity to maintenance of the steady-state pH i .
This result is consistent with previous observations on the role of Na ϩ /H ϩ exchanger activity in maintaining the steady-state pH i in a wide variety of epithelia such as renal cells (23) (24) (25) , retinal pigment epithelial cells (26 -28) , corneal epithelium (29), human esophageal epithelial cells (30) , nasal epithelial cells (18) , and lung epithelial cells (31) (32) (33) (34) (35) .
In this study, we have shown the synthetic glucocorticoid dexamethasone stimulated a rapid pH i recovery in bronchial epithelial cells following an acid load. The dependence on external Na ϩ and the sensitivity to the Na ϩ /H ϩ exchanger inhibitor EIPA of the dexamethasone effect on the pH i recovery strongly suggests that this response is mediated by stimulation of the Na ϩ /H ϩ exchange. Stimulation of the Na ϩ /H ϩ exchanger may reflect an increase in the turnover rate (V max ) and/or a change in its activation set point, which is regulated by H ϩ allosteric modulation (61, 62) . The set point of the exchanger is the pH i value at which the exchanger ceases to produce a net extrusion of H ϩ . In our experiments, the pH i dependence of the EIPA-sensitive H ϩ flux measured with or without dexamethasone (Fig. 3) indicates that dexamethasone increased the V max of the Na ϩ /H ϩ exchange. Dexamethasone did not affect the basal steady-state pH i . However, after an acid load a higher plateau value of pH i was reached with dexamethasone, suggesting that dexamethasone causes a shift in the set point of the exchanger to more alkaline pH i values. The lack of effect of the steroid on basal pH i may indicate an intracellular acidification is first required for dexamethasone activation of the exchanger or the set point is close to the basal pH i level. Perfusion with NMDG (Na ϩ substitution) did not completely inhibit the pH i recovery after an acid load, whereas EIPA completely abolished it. This difference is compatible with Na ϩ /H ϩ activation at the early phase of the pH i recovery (initial rate). EIPA rapidly and completely abolished Na ϩ /H ϩ activity, whereas the effect of the ionic substitution of Na ϩ by NMDG depends on the perfusion rate and might not be completed at the early stage of the recovery. The effects of glucocorticoids on pH i regulation and Na ϩ /H ϩ exchange have been widely reported in epithelial tissues. The increased expression of the NHE3 isoform by glucocorticoids has been reported in rat renal brush border (36) , opossum kidney cells (37) , proximal tubule cells (3, 38, 39) , rabbit ileal brush border (2) , and the NHE1 isoform in intra-hepatic biliary epithelium (40) . In contrast, our study showed that dexamethasone stimulated pH i recovery through a rapid cycloheximide-insensitive mechanism that is not compatible with a genomic action. A nongenomic response to dexamethasone is consistent with previous reports of the rapid effects of mineralocorticoid and glucocorticoid hormones on Na ϩ /H ϩ exchanger activity in other epithelia (11-13, 41, 42) . Rapid nongenomic effects of glucocorticoids have been described in tissues such as endometrial cells (4), vascular smooth mus- cle (5, 6) , human folliculostellate cells (43) , renal cortical collecting ducts (7), and airway epithelium (10) . Recently, a nongenomic effect of glucocorticoids has been reported in the allergic asthma reaction (44) . The rapid pH i responses to glucocorticoid in human airway epithelium raise the possibility of new therapeutic strategies for inflammatory airway disease associated with an airway acidification (asthma and cystic fibrosis).
The cellular and molecular mechanisms involved in rapid glucocorticoid responses are only partially described, and their physiological role has not yet been elucidated (8, 9) . Here we have investigated the cellular mechanisms involved in the rapid response to dexamethasone on pH i in airway epithelial cells. A role for the nuclear glucocorticoid receptor has been reported for some nongenomic actions of steroids (4, 43, 45, 46) . However, in our study, the insensitivity of the dexamethasone-induced pH i response to glucocorticoid and mineralocorticoid receptor antagonists indicates the response is not mediated by the classical steroid receptors. However, the higher potency of fluticasone compared with aldosterone on pH i regulation after an acid load suggests the involvement of a receptor selective for glucocorticoids but distinct from the nuclear glucocorticoid receptor responsible for the genomic action of glucocorticoids. These results are consistent with other rapid responses to glucocorticoids that do not involve the "classical" nuclear receptor (6, 10, 47) . The sensitivity of the response to pertussis toxin may indicate the involvement of a novel membrane-associated receptor, and the identification of membrane-binding sites for glucocorticoids supports this hypothesis (48 -50) . The rapid dexamethasone effect on pH i recovery displayed a bell-shaped concentration dependence that can be explained by desensitization of the receptor at higher steroid concentrations as already reported from other studies of the nongenomic effects of steroid hormones (58, 59) .
Because activation of the Na ϩ /H ϩ exchanger in a wide variety of tissues has been shown to occur through protein phosphorylation (41, 43) , we tested the possible involvement of several kinases in the rapid response to dexamethasone. Our data showed a sensitivity of the rapid dexamethasone effects on pH i regulation to PKA and ERK1/2 MAP kinase inhibitors. In addition, because our results also demonstrate that PKA and MAPK activities are up-regulated in response to dexamethasone in less than 5 min, we conclude that dexamethasone stimulates Na ϩ /H ϩ activity through PKA and ERK1/2 MAP kinase activation. A role for PKA in Na ϩ /H ϩ activation has been reported in renal and intestinal epithelium (51) (52) (53) . The stimulation of the Na ϩ /H ϩ exchanger by other kinases has also been described. In endothelial and renal epithelial cells, ERK1/2 MAPK was shown to be involved in Na ϩ /H ϩ activation (54, 55) . Steroids such as 1,25-OH-D 3 , 17␤-estradiol, and aldosterone have been reported to produce a nongenomic response on calcium signaling through PKA stimulation (56 -60) and MAPK activation (60) . In our study, the simultaneous exposure of the cells to both inhibitors did not produce an additive inhibitory effect on the dexamethasone-induced pH i response, suggesting that PKA and ERK1/2 MAPK lie within common convergent signaling cascade. In addition, the inhibition of ERK1/2 phosphorylation had no effect on PKA phosphorylation by dexamethasone, whereas the PKA antagonist inhibited ERK1/2 activation by dexamethasone. These latter results indicate that dexamethasone stimulation of ERK1/2 is dependent on PKA activation. The pertussis toxin inhibition of the dexamethasone effects on PKA activation and on pH i recovery after the acid load suggests a role for a G i protein-coupled receptor in transducing the rapid response to dexamethasone.
In conclusion, we show that dexamethasone stimulates Na ϩ /H ϩ exchanger activity through a rapid nongenomic pathway that does not implicate the classical nuclear receptors for glucorticoids or mineralocorticoids but implicates a novel signaling cascade involving sequentially a G i protein-coupled receptor, adenylate cyclase, cAMP, PKA, and ERK1/2 activation.
